GLOBAL BREAST IMPLANT PROPOSED LIABILITY SETTLEMENT
This article was originally published in The Gray Sheet
Executive Summary
GLOBAL BREAST IMPLANT PROPOSED LIABILITY SETTLEMENT allocates up to $81.5 mil. for foreign claimants who developed specified diseases and conditions following receipt of silicone gel implants. Under the proposed $4.25 bil. settlement ("The Gray Sheet" April 18, p. 8), $2.715 bil. would be allocated to a Disease Compensation Program that would furnish benefits for women who have one of the specified conditions or develop one in the next 30 years. Up to 3% of the funds in the disease compensation program will be available to foreign claimants.